Detalhe da pesquisa
1.
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer.
Br J Cancer
; 130(3): 450-456, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110665
2.
Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study.
Int J Gynecol Cancer
; 33(12): 1861-1868, 2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875323
3.
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
Breast Cancer Res Treat
; 168(2): 389-399, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29230663
4.
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trial.
Lung Cancer
; 191: 107538, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552544
5.
Two Enhances the Cisplatin Sensitivity of Cervical Cancer Cells via Suppression of c-MET Expression.
Iran J Public Health
; 52(7): 1476-1486, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37593506
6.
Efficacy and Safety in Proton Therapy and Photon Therapy for Patients With Esophageal Cancer: A Meta-Analysis.
JAMA Netw Open
; 6(8): e2328136, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37581887
7.
Neoadjuvant osimertinib and chemotherapy for stage IIIA primary pulmonary carcinosarcoma with EGFR 19DEL mutation: A case report.
Front Oncol
; 13: 1145021, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969031
8.
Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial.
Lancet Respir Med
; 9(9): 1021-1029, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34280355
9.
The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection.
Sci Rep
; 8(1): 2535, 2018 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29416061